Metabolic
Place your order for preplated version of libraries or request for customization and we configure the best screening set for your projects and inventory.
Write usProduct name
Size
Description
Download
39,301 compounds
Set of covalent inhibitors with warheads that target cysteine.
5000 compounds
Cytosolic phospholipase A2 (GIVA cPLA2) is involved in a number of inflammatory diseases. Synthetic inhibitors of GIVA cPLA2 attracted great interest as potential antiinflammotory drugs
1400 compounds
The library contains 1400 compounds that seems to be analogues of approved drugs.
31,972 compounds
Serine Proteases Inhibitors Library is a set of small-molecule compounds that target serine proteases and can be used in anticancer drug discovery.
1,156 compounds
Purine Based Nucleoside Mimetics Library is nucleoside analogues that mimic metabolic purines. They are extracellular messengers and endogenous modulators.
31,000 compounds
PRMT Library is set of small-molecule compounds with reported affinity against cancer-assosiated PRMTs.
2,081 compounds
Proline Kinase Library is a set of kinase inhibitors. These kinases play a crucial role in diverse cellular processes and human diseases.
19,000 compounds
PI3K-Targeted Library is a set of small-molecule inhibitors of PI3K signaling pathway. They can be used in effective inhibiting tumor progression.
2,292 compounds
Nucleoside Mimetics Library is a set of modified nucleosides that are used as antiviral and antitumor drugs. They were also designed for HIV therapy.
4,805 compounds
MEF2-HDAC (class II) Modulators Library is a set of drug-like compounds aimed at modulating PPI of MEF2 with HDAC involved in physiological processes.
2,230 compounds
Developmental Pathway Hh/Wnt Set is inhibitors of the Hedgehog and Wnt-signaling pathways implicated in cancer.
7,801 compounds
Set of small-molecule compounds that can target cysteine proteases and be used in drug development for cancer, viral, infections treatment.
5,000 compounds
Carbonic anhydrase II library is a set of compounds belonging to the sulfonamides, mercaptans and phenols aimed at modulating of Carbonic anhydrase II activity
15,080 compounds
Molecules from c-Met Library target receptor tyrosine kinase. It prevents binding hepatocyte growth factor with c-Met which can lead to cancer.
4,550 compounds
Autophagy-Targeted Library is a set of small-molecule modulators for the regulation of autophagy.
18,000 compounds
Antimitotic Tubulin Library is a set of small-molecule tubulin binders. These inhibitors are potential antimitotic drugs for anticancer therapy.
17,000 compounds
Angiogenesis Library is a set of small-molecule compounds that target proteins involved in new blood vessels forming.
15,000 compounds
Akt Targeted Library is a set of small-molecule inhibitors of the Akt-signaling network. These inhibitors are widely used in cancer treatment.
3,271 compounds
Purinergic Library is a set of purinergic receptor antagonists. Such antagonists are used for thrombosis and stroke treatment.
9,149 compounds
Lipid Metabolism Library is a set of small-molecule modulators of proteins involved in lipid metabolism.
23,000 compounds
Cardiovascular Library is a set of small-molecule compounds with vast target space for cardiovascular disease drug discovery.
40,000 compounds
Small-molecule compounds that can be used in GPCR drug discovery. Dysregulation of these receptors causes diabetes, CNS disorders.
12,206 compounds
Set of small-molecule compounds that inhibit MCL1 thus restoring the apoptotic pathway in tumor cells.
4,723 compounds
Voltage-Gated Ion Channel-Targeted set is small molecule compounds that contribute to treating pain.
10,813 compounds
Neurotransmitter Transporter Inhibitors Library is a set of small-molecule inhibitors. They are used to treat mental disorders.
28,284 compounds
CNS MPO Library is a set of drug-likeness designed via Multi-Parameter Optimization for improved BBB-permeability.
23,432 compounds
CNS BBB Library is a set of blood-brain barrier permeable compounds with high chemical diversity and novelty of structures.
7,123 compounds
Set of GABA receptor antagonists. These drug-like compounds inhibit the action of GABA and produce stimulant and convulsant effects.
8,000 compounds
Type II Kinase Inhibitors Library is a set of non-ATP site inhibitors or activators that bind to an extended ATP site including a back pocket.
12,000 compounds
Diacylglycerol kinase Inhibitors Library is a set of small-molecules that can inhibit the progression of cancer and innate cytotoxic immunocytes.
3,900 compounds
RPTP Targeted Library is small-molecule inhibitors. Disruption of protein tyrosine phosphorylation contributes to a variety of human diseases.
6,767 compounds
Set of RAR receptor antagonists. The retinoic acid receptor is a type of nuclear receptor which can also act as a transcription factor.
5,000 compounds
Glucocorticoid Receptors Library is small-molecule selective modulators of GR which regulates gene transcription.
5,000 compounds
BRD4 Targeted Library is a set of small-molecule compounds that inhibit transcriptional and epigenetic regulator - BRD4.
214,102 compounds
PPI Library is a set of small-molecule modulators that have been designed for disrupting PPI and reducing its drawbacks.
68,388 compounds
PPI Helix Turn 3D Mimetics Library was designed on sp3-enriched scaffolds that mimic key recognition elements of protein secondary structure.
2,335 compounds
Macrocycles Library is a set of macrocyclic peptidomimetics that are potential PPI modulators. It is unique spiro and fused scaffolds.
9,487 compounds
Set of PPI modulators. Cyclic lactam amides result from the Ugi reaction of bifunctional keto carboxylic acids.
4200 compounds
The use of covalently binding inhibitors is steadily growing, with numerous molecules progressing through the stages of clinical trials and even make it to become marketed drugs.
24,737 compounds
Alpha-Helix Mimetics Library is a set of peptidomimetics. Alpha-helices are key recognition elements of protein secondary structure.
21,000 compounds
Epitranscriptome Focused Small Molecule Library modulates the activity of proteins involving in aberrant RNA modification.
25,883 compounds
Focused Epigenetics Library is a set of small-molecule modulators that target epigenetic proteins.
50,410 compounds
Anti-Aging Library is small molecules targeting cellular pathways and biological targets that are implicated in aging.
1,503 compounds
3D Mimetics PPI Library is a set of small-molecule compounds that mimic key recognition elements of protein secondary structure.
498 compounds
Steroid-like compounds library is steroid-based molecules that regulate biological function. These synthetic steroids can treat inflammation.
9,753 compounds
Indole Derivatives Library is indole-based compounds. These heterocyclic compounds are active molecules with anti-inflammatory effects.
90,769 compounds
Beyond the Flatland Library sp3-enriched is a set of saturated small-molecules with chemical properties for a faster transition of compounds from discovery to drugs.
4,063 compounds
3D Fragment Library is a set of small-molecule compounds with diverse and well-developed 3D-shapes for HTS and fragment-based drug discovery.
11,269 compounds
Fragments Library is a set of small-molecules with high diversity, reduced structural complexity, drug-likeness. They possess a potential for "fragment evolution” and “fragment linking".
799 compounds
Smart library of covalent inhibitors and fragments with a wide range of reactivity warheads.
4,561 compounds
Natural-Product-Based Library is a set of small-molecule compounds. Natural products have proven successful modulators of difficult targets.
Tags
Custom ChemistryNovel Scaffolds and Discovery LibrariesCustom Building Blocks for DNA Encoded LibrariesScale up SynthesisMacrocycle CompoundsIn silico Drug Design (CADD)PROTACADME, DMPKMedicinal ChemistryDNA Encoded Libraries-CDI-CapabilitiesDiscovery BiologyAssay DevelopmentHigh Throughput Screening (HTS)Animal ModelsToxicology and SafetyChemistry, Manufacturing and ControlsPre-Plated SetRepresentative CompoundsNatural-Product3D-PharmacophoreMCE-18RepresentativeSoluble DiversityTargeted DiversitySmartTMAntiviralGPCR3DPhenotypic ScreeningCNS activityTranscription FactorsDrugs LibraryTarget ActivityTherapeutical DiversityCNSIon ChannelsProteases HumanKinases HumanPhosphatases HumanReceptors HumanOpportunistic PathogensCancerCardiovascularMetabolicImmune systemInfectionsMusculoskeletalDigestive systemRespiratory tractOtorhinolaryngologicNervous systemEyeMaleFemaleHemic and lymphaticCongenitalSkinEndocrineAnimalWoundsKinasesProteasesPhosphatasesNuclear receptorsOthersPPI modulatorsReceptor's ligandsEpigeneticMimeticsCyclic compoundsFragmentsPoolChemical classes AgroAllosteric Inhibitors